EARLY CARDIAC ALLOGRAFT FAILURE AFTER ORTHOTOPIC HEART-TRANSPLANTATION

被引:29
作者
HAUPTMAN, PJ
ARANKI, S
MUDGE, GH
COUPER, GS
LOH, E
机构
[1] BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA
[2] BRIGHAM & WOMENS HOSP, DEPT MED, DIV CARDIAC SURG, BOSTON, MA 02115 USA
[3] BRIGHAM & WOMENS HOSP, DEPT GEN SURG, BOSTON, MA 02115 USA
关键词
D O I
10.1016/0002-8703(94)90523-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early cardiac graft failure has been reported to occur in 4-25% of patients undergoing orthotopic heart transplantation. To further elucidate the characteristics and prognosis of patients with graft failure, we retrospectively identified 10 patients from a series of 212 consecutive recipients with catastrophic graft dysfunction in the absence of acute cellular rejection, right ventricular failure secondary to pulmonary hypertension and technical factors. We present a case report and the experience from one transplant center, a review of the literature and possible strategies for the management of early graft failure. Mean onset of graft failure was 6.5 days (range intraoperative to 23 days). Multivariable analysis revealed a longer total ischemic time in patients with early graft dysfunction (200 ± 14 vs. 166 ± 4 min). No episodes of hyperacute rejection were observed. Pathologic changes noted on biopsy or autopsy included ischemia in 9 and vascular rejection in 1. The mortality at 60 days was 50%. Early use of aggressive mechanical and pharmacological support is described and appears to be important for graft salvage. © 1994.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 29 条
[1]  
ARANKI SF, 1993, J CARDIAC SURG ANN T, V56, P149
[2]   DOPAMINE TREATMENT OF LOCALLY PROCURED DONOR HEARTS - RELEVANCE ON POSTOPERATIVE CARDIAC HISTOLOGY AND FUNCTION [J].
BALLESTER, M ;
OBRADOR, D ;
ABADAL, L ;
CLADELLAS, M ;
BORDES, R ;
MANITO, N ;
PONSLLADO, G ;
PADRO, JM ;
ARIS, A ;
CARALPSRIERA, JM .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1989, 22 (01) :37-42
[3]  
BOURGE RC, 1993, J HEART LUNG TRANSPL, V12, P549
[4]   IDENTIFICATION OF THE ANTIBODY TO VASCULAR ENDOTHELIAL-CELLS IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION [J].
BRASILE, L ;
ZERBE, T ;
RABIN, B ;
CLARKE, J ;
ABRAMS, A ;
CERILLI, J .
TRANSPLANTATION, 1985, 40 (06) :672-675
[5]   2 MAJOR SEROLOGIC EVENTS IN A SUCCESSFUL CARDIAC TRANSPLANT RECIPIENT - CIRCUMVENTION OF HYPERACUTE REJECTION DESPITE A POSITIVE DONOR LYMPHOCYTE-T CROSSMATCH AND LATE APPEARANCE OF PROBABLE ANTIIDIOTYPIC ANTIBODY [J].
BRAUN, WE ;
KLINGMAN, L ;
STEWART, RW ;
RATLIFF, N ;
TUBBS, R ;
ZACHARY, AA ;
TERESI, GA ;
RINCON, G ;
PROTIVA, D .
TRANSPLANTATION, 1988, 46 (01) :153-155
[6]  
COSTANZONORDIN MR, 1993, J HEART LUNG TRANSPL, V12, pS143
[7]   CARDIAC RETRANSPLANTATION IN THE CYCLOSPORINE ERA [J].
DEIN, JR ;
OYER, PE ;
STINSON, EB ;
STARNES, VA ;
SHUMWAY, NE .
ANNALS OF THORACIC SURGERY, 1989, 48 (03) :350-355
[8]   PROLONGED EXTRACORPOREAL LIFE-SUPPORT OF PEDIATRIC AND ADOLESCENT CARDIAC TRANSPLANT PATIENTS [J].
DELIUS, RE ;
ZWISCHENBERGER, JB ;
CILLEY, R ;
BEHRENDT, DM ;
BOVE, EL ;
DEEB, GM ;
CROWLEY, D ;
HEIDELBERGER, KP ;
BARTLETT, RH .
ANNALS OF THORACIC SURGERY, 1990, 50 (05) :791-795
[9]  
GALANTOWICZ ME, 1991, J THORAC CARDIOV SUR, V102, P148
[10]  
HEROUX AL, 1992, CIRCULATION, V86, P628